| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. David Chien CEO | HKEX Exchange | KYG6773B1005 ISIN |
| DE Country | 1,477 Employees | - Last Dividend | - Last Split | - IPO Date |
OrbusNeich Medical Group Holdings Limited operates as an investment holding company with a primary focus on designing, developing, manufacturing, trading in, selling, and marketing medical devices and instruments aimed at treating coronary and peripheral vascular diseases. The company's operational footprint spans various regions including Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. Founded in 2001 and headquartered in Shatin, Hong Kong, OrbusNeich Medical Group Holdings Limited operates under the umbrella of Harmony Tree Limited as its subsidiary. With its innovative product offerings and a wide-reaching geographic presence, the company plays a pivotal role in advancing the field of vascular intervention and treatment globally.
OrbusNeich Medical Group Holdings Limited offers an extensive portfolio of medical devices specifically designed to cater to the needs of percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The array of products includes:
Through its comprehensive product lineup, OrbusNeich Medical Group Holdings Limited supports healthcare professionals in improving patient outcomes in coronary and peripheral vascular disease treatments.